longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SL PHARM has obtained the drug registration certificate for nitroglycerin spray

Zhitong
Apr 8, 2025 at 08:53 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, SL PHARM has announced that the company recently received the "Drug Registration Certificate" for nitroglycerin spray (brand name: Lishengle®) approved by the National Medical Products Administration. This approval makes the company the first in the country to obtain approval for a new formulation of nitroglycerin spray, and it is currently the only one in the domestic market. This approval is considered equivalent to passing the consistency evaluation

According to the Zhitong Finance APP, SL PHARM (002038.SZ) announced that the company recently received the "Drug Registration Certificate" for nitroglycerin spray (brand name: Lishengle®) approved by the National Medical Products Administration. This approval makes the company the first in the country to obtain approval for a new formulation of nitroglycerin spray, and it is currently exclusive in the domestic market. This approval is considered equivalent to passing the consistency evaluation

Login to unlock7characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

SL PHARM

SL PHARM

002038.SZ

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--

LongbridgeAI